Correlation Between Arcellx and Inozyme Pharma
Can any of the company-specific risk be diversified away by investing in both Arcellx and Inozyme Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Arcellx and Inozyme Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Arcellx and Inozyme Pharma, you can compare the effects of market volatilities on Arcellx and Inozyme Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Arcellx with a short position of Inozyme Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Arcellx and Inozyme Pharma.
Diversification Opportunities for Arcellx and Inozyme Pharma
-0.51 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Arcellx and Inozyme is -0.51. Overlapping area represents the amount of risk that can be diversified away by holding Arcellx and Inozyme Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Inozyme Pharma and Arcellx is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Arcellx are associated (or correlated) with Inozyme Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Inozyme Pharma has no effect on the direction of Arcellx i.e., Arcellx and Inozyme Pharma go up and down completely randomly.
Pair Corralation between Arcellx and Inozyme Pharma
Given the investment horizon of 90 days Arcellx is expected to generate 0.68 times more return on investment than Inozyme Pharma. However, Arcellx is 1.47 times less risky than Inozyme Pharma. It trades about 0.08 of its potential returns per unit of risk. Inozyme Pharma is currently generating about 0.04 per unit of risk. If you would invest 3,149 in Arcellx on August 31, 2024 and sell it today you would earn a total of 5,658 from holding Arcellx or generate 179.68% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Arcellx vs. Inozyme Pharma
Performance |
| Timeline |
| Arcellx |
| Inozyme Pharma |
Arcellx and Inozyme Pharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Arcellx and Inozyme Pharma
The main advantage of trading using opposite Arcellx and Inozyme Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Arcellx position performs unexpectedly, Inozyme Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Inozyme Pharma will offset losses from the drop in Inozyme Pharma's long position.| Arcellx vs. Nuvalent | Arcellx vs. Ventyx Biosciences | Arcellx vs. Amylyx Pharmaceuticals | Arcellx vs. Day One Biopharmaceuticals |
| Inozyme Pharma vs. Day One Biopharmaceuticals | Inozyme Pharma vs. X4 Pharmaceuticals | Inozyme Pharma vs. Acumen Pharmaceuticals | Inozyme Pharma vs. Mereo BioPharma Group |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Other Complementary Tools
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |